| Completed | Absorption, Metabolism, and Excretion of CYC065 in Healthy Male Subjects Healthy | EARLY_Phase 1 | 2023-03-03 |
| Unknown | A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma Solid Tumor, Adult Lymphoma | Phase 1 / Phase 2 | 2022-04-14 |
| Suspended | A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) Leukemia, Myelodysplastic Syndrome(MDS) | Phase 1 / Phase 2 | 2021-10-22 |
| Unknown | A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma Solid Tumor, Adult, Lymphoma | Phase 1 / Phase 2 | 2021-07-12 |
| Completed | CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS AML, MDS | Phase 1 | 2019-08-02 |
| Terminated | A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS AML, Adult, Myelodysplastic Syndromes, ALL, Adult | Phase 1 | 2019-03-25 |
| Completed | CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL Relapsed or Refractory Chronic Lymphocytic Leukemia | Phase 1 | 2019-01-25 |
| Completed | A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers Cancer | Phase 1 | 2015-09-28 |
| Completed | A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 3 | 2011-10-01 |
| Unknown | Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2010-06-17 |
| Completed | A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2009-04-01 |
| Terminated | A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer Non-small Cell Lung Cancer | Phase 2 | 2008-12-01 |
| Completed | Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients Acute Myeloid Leukemia | Phase 2 | 2007-12-01 |
| Terminated | A Phase I Pharmacologic Study of CYC116, an Oral Aurora Kinase Inhibitor, in Patients With Advanced Solid Tumo Solid Tumors | Phase 1 | 2007-06-01 |
| Terminated | A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma Cutaneous T-cell Lymphoma (CTCL) | Phase 2 | 2007-04-01 |
| Terminated | Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer Non-small Cell Lung Cancer | Phase 2 | 2006-08-09 |
| Completed | Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes Leukemias, Myelodysplastic Syndromes | Phase 1 | 2006-01-01 |